Abbott Laboratories (ABT)

NYQ – Real Time Price. Currency in USD

111.03

+1.30 (1.19%)

Market open: Aug 12, 2026, 3:08 PM EDT

109.55

-0.17 (-0.15%)

Previous after-hours: Aug 11, 2026, 7:54 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

44.33B

41.95B

40.11B

43.65B

Cost of goods sold

-20.95B

-20.63B

-20.07B

-21.33B

Gross Profit

23.37B

21.32B

20.04B

22.32B

Operating expenses (excl. COGS)

-15.11B

-14.47B

-13.60B

-13.96B

Operating Income

8.26B

6.85B

6.43B

8.36B

Non-operating income, total

202M

162M

229M

-56M

Pretax income

8.47B

7.01B

6.66B

8.31B

Equity in earnings

Taxes

-1.94B

6.39B

-941M

-1.37B

Non-controlling/minority interest

After tax other income/expense

-24M

-51M

-22M

-28M

Net income before discontinued operations

6.50B

13.35B

5.70B

6.91B

Discontinued operations

Net income

6.50B

13.35B

5.70B

6.91B

Dilution adjustment

Preferred dividends

Abbott Laboratories (ABT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Abbott Laboratories (ABT)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Abbott Laboratories (ABT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Abbott Laboratories (ABT)

Income Statement (Annual)

Income Statement (Annual)